Overview

Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia

Status:
Unknown status
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The aim of the present study was to investigate the efficacy of aripiprazole in management of pre-existing neuroleptic-induced tardive dyskinesia
Phase:
Phase 4
Details
Lead Sponsor:
Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan
Collaborator:
Department of Health
Treatments:
Antipsychotic Agents
Aripiprazole